Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats

The Journal of Clinical Investigation
F CosentinoT F Lüscher

Abstract

Constitutive nitric oxide synthase (cNOS) with insufficient cofactor (6R)-5,6,7,8-tetrahydrobiopterin (H4B) may generate damaging superoxide (O2-). This study was designed to determine whether cNOS-dependent generation of O2- occurs in spontaneously hypertensive rats (SHR) before the onset of hypertension. Aortas from 4-wk-old SHR and Wistar-Kyoto rats were used. cNOS was stimulated by calcium ionophore A23187. In situ measurements of nitric oxide and hydrogen peroxide by electrochemical sensors and O2- production by chemiluminescence method were performed. Isometric tension was continuously recorded. H4B by high performance liquid chromatography and [3H]citrulline assay were determined in homogenized tissue. The A23187-stimulated production of O2- and its superoxide dismutase product hydrogen peroxide were significantly higher, whereas nitric oxide release was reduced in SHR aortas, with opposite results in the presence of exogenous H4B. Furthermore, NG-monomethyl-L-arginine inhibited the generation of cNOS-dependent O2- by approximately 70%. Natural H4B levels were similar in both strains; however, equivalent cNOS activity required additional H4B in SHR. The endothelium-dependent relaxations to A23187 were significantly inhib...Continue Reading

References

Sep 8, 1978·Science·I Fridovich
Nov 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·K NakazonoM Inoue
Jun 18, 1991·European Journal of Pharmacology·D SalveminiJ Vane
Sep 1, 1990·Prostaglandins, Leukotrienes, and Essential Fatty Acids·P S PrabhaG Ramesh
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D D ReesS Moncada
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·L J IgnarroG Chaudhuri
Mar 12, 1987·Journal of Immunological Methods·H Gyllenhammar
May 1, 1995·Naunyn-Schmiedeberg's Archives of Pharmacology·B Mayer, E R Werner
Jul 30, 1993·Biochemical and Biophysical Research Communications·T MalinskiD Bohr
Jan 1, 1993·Free Radical Research Communications·K V Kumar, U N Das
May 17, 1993·FEBS Letters·G Werner-FelmayerH Wachter

❮ Previous
Next ❯

Citations

May 22, 2001·Archives of Biochemistry and Biophysics·T YoneyamaK Hatakeyama
Aug 10, 2006·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Akos BaráthPéter Monostori
Dec 25, 2010·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Ling TangJiangtao Yan
Feb 15, 2001·Current Hypertension Reports·A WarnholtzT Münzel
Feb 15, 2001·Current Hypertension Reports·F Cosentino, T F Lüscher
Nov 22, 2001·Current Hypertension Reports·L V d'Uscio, T F Lüscher
Mar 9, 2002·Current Hypertension Reports·Christopher S Wilcox
Jan 18, 2003·Current Hypertension Reports·Aroon D Hingorani
Apr 8, 2006·Current Hypertension Reports·Sven WassmannGeorg Nickenig
Apr 29, 2010·Current Hypertension Reports·Ana M Briones, Rhian M Touyz
Dec 31, 2003·Archives of Gerontology and Geriatrics·Markus BachschmidVolker Ullrich
Mar 24, 2004·Archives of Medical Research·Armando Rojas Rubio, Miguel A Morales-Segura
May 26, 2005·Biochemical and Biophysical Research Communications·Yuan-Ning CaoKazuo Kitamura
Mar 18, 2004·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Hiroaki Shimokawa, Tetsuya Matoba
Dec 28, 1999·European Journal of Pharmacology·V S LemosS F Côrtes
Apr 13, 2000·Pharmacology & Therapeutics·A M Shah, P A MacCarthy
May 9, 2001·Biochimica Et Biophysica Acta·G HsiaoM H Yen
Feb 11, 1999·Journal of the American College of Cardiology·T HeitzerH Drexler
Jan 15, 2000·Journal of the American College of Cardiology·S UedaT Imaizumi
Oct 17, 2002·Nitric Oxide : Biology and Chemistry·Huige LiUlrich Förstermann
Apr 16, 2002·Current Opinion in Pharmacology·Christine G Schnackenberg
Dec 11, 2003·Atherosclerosis. Supplements·Karsten Sydow, Thomas Münzel
Aug 23, 2001·International Immunopharmacology·P ForsytheA D Befus
Mar 7, 2008·Journal of Human Hypertension·M PorkertA A Quyyumi
Feb 5, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Reiner Wiest, Roberto J Groszmann
Dec 20, 2000·The Journal of Experimental Medicine·B van der LooT F Lüscher
Mar 7, 2008·Antioxidants & Redox Signaling·Christian DellesAnna F Dominiczak
Aug 19, 2008·Antioxidants & Redox Signaling·Shane R ThomasGrant R Drummond
Jul 23, 2008·American Journal of Therapeutics·Valmore BermúdezZafar Israili
Dec 3, 2005·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Malcolm J Jackson
Oct 14, 2004·Clinical and Experimental Pharmacology & Physiology·Shaun L Sandow
Jul 5, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Xiaosun ZhouJoseph L Unthank
Aug 12, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Mykhaylo KordaTadeusz Malinski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.